index - Organisation de la cellule musculaire et thérapie de la myopathie centronucléaire autosomique dominante Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

55 %

Mots clés

Cytosquelette Dynamine ACTN2 Myopathie Duchenne muscular dystrophy DMD AD-CNM Autophagosome maturation Myosin Autophagy Dystrophie musculaire de Duchenne BAR proteins Congenital myopathy Dynamin 2 Developmental biology Cell migration Clathrine Adhesion Dynamin Muscle Ctdnep1 RNA interference Actin nucleus Adeno-associated virus CTL Amphiphysin Atrial cardiac defects Myopathy Caveolae CAV-3 gene Cross-presentation Charcot-Marie-Tooth Becker muscular dystrophy BMD Cross-bridge kinetics Cell proliferation Outflow tract Caveolin Dystrophie musculaire d'Emery Dreifuss BAF Autosomal dominant centronuclear myopathy Cancer Adeno-Associated virus DMyHC BMP signaling Satellite cell Cavéoles Centronuclear myopathy Mechanotransduction Cell signaling Cytoskeleton Disease heterogeneity Antisense oligonucleotides Neural crest cells Biomarkers Skeletal muscle Actin Core myopathy Cellules de crête neurale Clathrin Developmental myosin heavy chain Nesprin Cellular neuroscience Caveolins Correlative microscopy Disease modifiers Dominant centronuclear myopathy Nucleus Allele-specific silencing Alpha-actinin-2 Adult patients Coeur Domaine LEM Cavins Autophagy cellular Duchenne Muscular Dystrophy AFM Adeno-associated virus vector DNM2 Autophagosome Cardiomyopathies AAV8 Nuclear envelope Allele specific RNA interference AAV Cardiotoxin Duchenne muscular dystrophy Muscular dystrophy Allele-specific silencing therapy Skin Endocytosis Lamin Animal models of human disease Diaphragm Biophysics Allele‐specific silencing therapy Gene therapy Migration A-type lamins Dullard Atrial heart defects Dynamin overexpression